Silibinin, a polyphenolic flavonoid also known as silybin [4], is the major active constituent of silymarin and the major biologically active compound of milk thistle [1], a plant that has traditionally been used to treat different ailments and illnesses, due to the properties it exerts and the ability of some of the active constituents found in it, as Silibinin, to be used as an effective chemo-preventive agent in various types of cancer, suppressing cancer cell growth and inhibiting colon cancer stem-like cells [6], being also studied for its inhibitory effects on certain types of breast cancer cells [9,10], and many other anti-neoplastic effects in a variety of in vitro and in vivo cancer models, including skin, breast, lung, colon, bladder, prostate and kidney carcinomas [15]. But this time a study showed for first time how Silymarin was ineffective for the treatment of Hepatitis C. Image: Eran Finkle under CC license (CC by 2.0).
The study was conducted was conducted using a double-blind, placebo-controlled trial at 4 medical centers in the United States, and included 154 persons with chronic Hepatitis C virus infection who were previously and unsuccessfully treated with interferon-based therapy [24].
SYLIBUM MARIANUM
Family: Asteraceae
Genus: Sylibum
Common name: Milk thistle, גדילן מצוי,